Correlation Between Immunovant and Mirati Ther

Can any of the company-specific risk be diversified away by investing in both Immunovant and Mirati Ther at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunovant and Mirati Ther into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Immunovant and Mirati Ther, you can compare the effects of market volatilities on Immunovant and Mirati Ther and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunovant with a short position of Mirati Ther. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunovant and Mirati Ther.

Diversification Opportunities for Immunovant and Mirati Ther

-0.12

Correlation Coefficient

Immunovant  Mirati Ther

Good diversification

The 3 months correlation between Immunovant and Mirati is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Immunovant and Mirati Ther in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mirati Ther and Immunovant is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunovant are associated (or correlated) with Mirati Ther. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mirati Ther has no effect on the direction of Immunovant i.e., Immunovant and Mirati Ther go up and down completely randomly.

Pair Corralation between Immunovant and Mirati Ther

If you would invest  2,834  in Immunovant on July 23, 2024 and sell it today you would earn a total of  113.00  from holding Immunovant or generate 3.99% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	4.76%
Values	Daily Returns

Immunovant  vs.  Mirati Ther

Immunovant

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Immunovant are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Immunovant may actually be approaching a critical reversion point that can send shares even higher in November 2024.

Mirati Ther

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mirati Ther has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Mirati Ther is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Immunovant and Mirati Ther

The main advantage of trading using opposite Immunovant and Mirati Ther positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunovant position performs unexpectedly, Mirati Ther can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mirati Ther will offset losses from the drop in Mirati Ther's long position.

The idea behind Immunovant and Mirati Ther pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.